Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-NH-PEG2-C2-NH-Boc, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon-targeting Thalidomide ligand with a PEG linker for the synthesis of dBRD9 (compound 6). This selective BRD9 probe PROTAC degrader is utilized in researching BAF complex biology.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | Inquiry | Backorder | |
100 mg | Inquiry | Backorder |
Description | Thalidomide-NH-PEG2-C2-NH-Boc, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon-targeting Thalidomide ligand with a PEG linker for the synthesis of dBRD9 (compound 6). This selective BRD9 probe PROTAC degrader is utilized in researching BAF complex biology. |
In vitro | dBRD9, at concentrations ranging from 0 to 1 μM, significantly inhibits cell proliferation, demonstrating effectiveness that is 10 to 100 times greater than that of non-degrading probes[1]. |
Alias | Thalidomide-NH-PEG2-C2-NH-Boc |
Molecular Weight | 504.53 |
Formula | C24H32N4O8 |
Cas No. | 2097509-40-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.